×
戻る Agenda
DA01: Current and Future Status of Drug Development in Japan, the US, and Europe under COVID-19 Pandemic
Session Chair(s)
Hironobu Saito, PHD
Corporate Advisor, Daiichi Sankyo Co., Ltd., Japan
Junko Sato, PHD
Associate Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan